Verastem
(NASDAQ:VSTM)
$0.395
-0.025[-5.95%]
At close: Dec 6(Delayed 15-Minutes)
Get Real Time Here
$0.3715
-0.0235[-5.95%]
After Hours: 4:16PM EDT
Day Range0.38 - 0.4352 Wk Range0.29 - 2.62Open / Close0.41 / 0.4Float / Outstanding187M / 210.1M
Vol / Avg.915.5K / 1.6MMkt Cap83MP/E-50d Avg. Price0.46
Div / Yield-Payout Ratio-Total Float187MEPS-0.09

Verastem Stock (NASDAQ:VSTM), Quotes and News Summary

Verastem Stock (NASDAQ: VSTM) stock price, news, charts, stock research, profile.

Loading...
Day Range0.38 - 0.4352 Wk Range0.29 - 2.62Open / Close0.41 / 0.4Float / Outstanding187M / 210.1M
Vol / Avg.915.5K / 1.6MMkt Cap83MP/E-50d Avg. Price0.46
Div / Yield-Payout Ratio-Total Float187MEPS-0.09
TalkMarkets - Oct 29, 2022, 4:34PM
InvestorsObserver - Oct 10, 2022, 1:03PM
Seeking Alpha - Sep 13, 2022, 8:14AM
Seeking Alpha - Sep 7, 2022, 8:23AM
InvestorsObserver - Aug 8, 2022, 12:01PM
Seeking Alpha - Aug 8, 2022, 8:20AM
Seeking Alpha - Jun 29, 2022, 9:25AM
InvestorsObserver - May 23, 2022, 6:57AM
InvestorPlace - May 19, 2022, 6:00PM
InvestorsObserver - May 10, 2022, 10:24AM
InvestorsObserver - May 9, 2022, 6:55AM
InvestorsObserver - Apr 21, 2022, 10:40AM
Seeking Alpha - Apr 19, 2022, 9:49AM
Sector: Health Care.Industry: Biotechnology
Verastem Inc is late-stage development biopharmaceutical company, committed to advancing new medicines for patients battling cancer. The company's first commercial product, COPIKTRA (duvelisib) is indicated for the treatment of adult patients with relapsed or refractory chronic lymphocytic leukemia/small lymphocytic lymphoma after at least two prior therapies and relapsed or refractory follicular lymphoma after at least two prior systemic therapies. The company's product pipeline candidate, defactinib, is a focal adhesion kinase inhibitor in development for the treatment of cancers where there are limited treatment options, including lung, ovarian, lymphoma, pancreatic, and other advanced cancers.

Earnings

see more
Q3 2022Est.ActualSurprise
EPS-0.120-0.080 0.0400
REV0
Q2 2022Est.ActualSurprise
EPS-0.110-0.110 0.0000
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
Q

How do I buy Verastem (VSTM) stock?

A

You can purchase shares of Verastem (NASDAQ: VSTM) through any online brokerage.

View our list of the best stock brokerages.

Q

What is the target price for Verastem (VSTM) stock?

A

The latest price target for Verastem (NASDAQ: VSTM) was reported by HC Wainwright & Co. on Monday, November 7, 2022. The analyst firm set a price target for 3.00 expecting VSTM to rise to within 12 months (a possible 659.49% upside). 4 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Verastem (VSTM)?

A

The stock price for Verastem (NASDAQ: VSTM) is $0.395 last updated Today at December 6, 2022, 9:00 PM UTC.

Q

Does Verastem (VSTM) pay a dividend?

A

There are no upcoming dividends for Verastem.

Q

When is Verastem (NASDAQ:VSTM) reporting earnings?

A

Verastem’s Q3 earnings are confirmed for Thursday, November 3, 2022.

Q

Is Verastem (VSTM) going to split?

A

There is no upcoming split for Verastem.

Q

What sector and industry does Verastem (VSTM) operate in?

A

Verastem is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.